Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance A Benson

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
The Journal of Infectious Diseases|February 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune ResponsesDavey Smith, Isabelle R Weir, Sydney Ramirez, et al.
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Annals of Global Health|December 16, 2024
Transforming the Health Research Workforce in Mozambique: Achievements of the Mozambique Institute for Health Education and Research (MIHER) over a 13‑Year JourneyEmília Virgínia Noormahomed, Sérgio Noormahomed, Matchecane Cossa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff, Stephen J Gange, Marina B Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2022
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial DiseaseRebekah M Dedrick, Bailey E Smith, Madison Cristinziano, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
Annals of Internal Medicine|October 7, 2014
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialJeffrey L Lennox, Raphael J Landovitz, Heather J Ribaudo, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
The Journal of Infectious Diseases|February 17, 2026
Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune ResponsesDavey Smith, Isabelle R Weir, Sydney Ramirez, et al.
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Annals of Global Health|December 16, 2024
Transforming the Health Research Workforce in Mozambique: Achievements of the Mozambique Institute for Health Education and Research (MIHER) over a 13‑Year JourneyEmília Virgínia Noormahomed, Sérgio Noormahomed, Matchecane Cossa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff, Stephen J Gange, Marina B Klein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2022
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial DiseaseRebekah M Dedrick, Bailey E Smith, Madison Cristinziano, et al.
Pageof 11